Ken Keyong Ren Insider Trading $CASI CASI Pharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ken Keyong Ren.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ken Keyong Ren. Ken Keyong Ren is CEO and Director in CASI Pharmaceuticals, Inc. ($CASI) and Chief Executive Officer in CASI Pharmaceuticals, Inc. ($CASI) and Director in CASI Pharmaceuticals, Inc. ($CASI).
Ken Keyong Ren in CASI Pharmaceuticals, Inc.
Trading Symbol: CASIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ken Keyong Ren: CEO and Director, Chief Executive Officer
Holdings: 15,000 shares
Current Value: $20,850
Latest Transaction: Jun 21 2019
$CASI Market Capitalization: $81.26M
$CASI Previous Close: $1.39
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ken Keyong Ren in CASI Pharmaceuticals, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2019 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Director | Option Exercise | A | 3.13 | 51,538 | 161,314 | 51,538 | |
Jan 31 2019 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.88 | 75,000 | 66,000 | 75,000 | |
Dec 06 2018 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.99 | 720,000 | 712,800 | 720,000 | |
Oct 05 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 1.11 | 308,571 | 342,514 | 308,571 | |
Jun 27 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 1.15 | 86,486 | 99,459 | 86,486 | |
Jun 03 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.86 | 280,701 | 241,431 | 280,701 | |
Mar 04 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 0.88 | 125,000 | 110,000 | 125,000 | |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.71 | 300 | 213 | 15,000 | 14.7 K to 15 K (+2.04 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.72 | 6,063 | 4,365 | 14,700 | 8.6 K to 14.7 K (+70.20 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.74 | 1,100 | 814 | 8,637 | 7.5 K to 8.6 K (+14.59 %) |
Jan 21 2016 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | CEO and Director | Buy | P | 0.73 | 7,537 | 5,502 | 7,537 | 0 to 7.5 K |
Apr 08 2015 | CASI | CASI Pharmaceutica ... | Ren Ken Keyong | Chief Executive Off ... | Option Exercise | A | 1.41 | 225,000 | 317,250 | 225,000 |
Page: 1